Literature DB >> 31405304

Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM.

Hei Ching Chow1, Tsz Him So1, Horace Cheuk Wai Choi1, Ka On Lam1.   

Abstract

Traditional Chinese medicine (TCM) herbs are commonly regarded to be safe with minimal toxicities in Chinese communities. Cancer patients who are receiving Western oncology therapy often concurrently take TCM herbs for anticancer and symptom relief purposes. We performed a literature review for current evidence on TCM herb-induced liver injury from an oncological perspective. A literature search on PubMed was performed to identify publications regarding TCM herbs and concoctions with hepatoprotective or hepatotoxic properties. Lists of commonly used herbs and their causality levels were compiled. In view of the wide range of evidence available, cases assessed by the well-established RUCAM (Roussel Uclaf Causality Assessment Method) algorithm were categorized as the highest level of evidence. More than one case of TCM herb-induced liver injury was confirmed by RUCAM in the following herbs and concoctions: Lu Cha (Camellia sinensis), Bai Xian Pi (Dictamnus dasycarpus), Tu San Qi (Gynura segetum), Jin Bu Huan (Lycopodium serratum), He Shou Wu (Polygoni multiflora), Ge Gen (Pueraria lobata), Dan Lu Tong Du tablet, Shou Wu Pian, Xiao Chai Hu Tang, Xiao Yin pill, and Yang Xue Sheng Fa capsule. Finally, TCM with anticancer or symptom relief uses were discussed in detail with regard to their hepatotoxic or hepatoprotective properties.

Entities:  

Keywords:  Chinese herbal medicine; RUCAM; cancer; hepatotoxicity; liver toxicity; oncology; traditional Chinese medicine

Mesh:

Substances:

Year:  2019        PMID: 31405304      PMCID: PMC6693029          DOI: 10.1177/1534735419869479

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


Introduction

Multiple studies have shown that there is widespread use of traditional Chinese medicine (TCM) among Chinese patients as an adjuvant to Western medicine in cancer treatment.[1-5] Another study revealed that the self-care of Chinese cancer patients has been heavily influenced by the TCM philosophy.[6] In addition to taking herbal medicines prescribed by Chinese medicine practitioners, it is also common for the general public to use proprietary Chinese medicine on their own or add herbs to meals and soups. A study found that over half of the Hong Kong cancer patients surveyed used at least one form of TCM. Furthermore, 60% of these patients who were receiving chemotherapy concurrently used TCM.[7] According to a Taiwanese survey, 69% of respondents thought that TCM is mild and has no ill effects at all.[8] TCM herbs and concoctions, like any drug, also have side effects and toxicities. Many oncologists do not encourage the concurrent use of TCM due to the potential of having adverse interactions between Chinese and Western drugs that may lead to hepatotoxicity. There have been numerous reports of liver injury caused by TCM herbs and concoctions. However, the establishment of causality varies in these reports. A typical example of TCM-induced liver toxicity is He Shou Wu, which is a popular herb for preventing hair loss and aging. A study found that only 30.6% of literature case reports demonstrate a high probability of He Shou Wu–induced liver injury causality.[9] The causality between TCMs and drug-induced liver injury was ascertained by various methods, such as by patient recall, clinical suspicion, exclusion, and algorithms. It is important to note the complexity and difficulty in establishing causality for TCM herbs. One difficulty is due to polypharmacy as TCM is rarely used as a single herb, and TCM may sometimes be used concomitantly with Western drugs. Another difficulty is contamination by heavy metals.[10] Evidence available in case reports, case series, and reviews may not be complete. If these confounders are not excluded, misdiagnosis and overreporting may occur. Hence, there is a need to categorize the cases in the existing literature into different evidence levels of causality. Focus should be given to hepatotoxic TCM for which clear evidence has been demonstrated by standardized causality assessment algorithms. RUCAM (Roussel Uclaf Causality Assessment Method), or its previous synonym CIOMS (Council for International Organizations of Medical Sciences), is the most commonly used causality instrument for drug-induced liver toxicity.[11] RUCAM is used to assess causality quantitatively, by applying numerical weighting to key features such as chronology and risk factors, and it generates an overall score to indicate the probability of causality. The RUCAM scale ranges as follows: 0, excluded; 1 to 2, unlikely; 3 to 5, possible; 6 to 8, probable; and ≥9, highly probable.[12] Furthermore, not all TCM herbs and concoctions cause hepatotoxicity. In fact, some of them have hepatoprotective effects against drug-induced liver injury, such as chemotherapy-induced hepatotoxicity. In this article, we present a review of the current literature to identify potentially hepatotoxic or hepatoprotective TCM that cancer patients may concurrently use with Western systemic therapies, and stratify them using causality levels to offer easier interpretation.

Methodology

Data Sources and Searches

We carried out a systematic search of the PubMed database on March 11, 2019, to identify publications of laboratory findings, case reports, case series, and review articles of TCM-induced hepatotoxicity. By using Medical Subject Headings, English articles that were associated with the terms “Chemical and Drug-Induced Liver Injury” and “Medicine, Chinese Traditional” were selectively included. Our search yielded 64 results.

Exclusion of Publications

Publications were excluded by the following criteria. Publications were excluded if They were unrelated to TCM-induced hepatotoxicity or hepatoprotection, or Access to the full article could not be obtained, or No specific TCM herbs or concoctions were named, or No significant results were directly shown with specific TCM herbs or concoctions. As a result, 14 publications were excluded from this review.

Data Analysis

Data Extraction

Fifty publications were analyzed. Individual herbs and herbal concoctions were identified. The scientific names of each herb and its corresponding Chinese name were determined. As a single TCM herb could have different scientific names (eg, Polygoni multiflori vs Polygonum multiflorum Thunb), results were grouped according to the Chinese name of the herb. The publications were then analyzed to yield the number of clinical cases and causality.

Duplication of Data

The references of these 50 publications were carefully inspected. There were case reports, case series, and reviews referring to the same event of hepatotoxicity caused by a certain TCM herb or concoction. In particular, 3 systematic reviews were published by the same author in 3 consecutive years, and each systematic review cited cases from the previous review. Duplicated data were discarded in this review.

Exclusion of TCM Herbs or Concoctions

If the publication failed to provide any of the aforementioned data (eg, number of cases), the reference lists of the primary and review articles were scanned. If the primary source could not be accessed, the data of the individual herb or concoction were also excluded.

Levels of Causality

Hepatotoxic herbs or concoctions

In view of the wide range of clinical causality ascertainment methods in the literature, as well as the fact that laboratory findings do not directly infer clinical significance, a stratified level of causality was devised in order to provide a clearer and more clinically oriented picture. Entries of hepatotoxic herbs or herbal concoctions found from the publications were categorized into 1 of the 4 following levels according to the following description:

Hepatoprotective herbs or concoctions

After excluding uncommonly used hepatoprotective herbs and herbal concoctions, only nonclinical ones remained; hence, they were not graded by causality levels.

Results

Lists of herbs and concoctions that were hepatotoxic or hepatoprotective, their respective causality levels, and number of cases are compiled in Tables 1 to 5.[9,13-46]
Table 1.

TCM Herbs That Were Assessed by RUCAM to Demonstrate Clear Causality of Hepatotoxicity.

中藥名Commonly Known asScientific NameLevel of CausalityNo. of Cases
刺五加Ci Wu Jia Acanthopanax senticosus [13,14] 41
澤瀉Ze Xie Alisma orientalis [13-15] 41
蘆薈Aloe Vera Aloe perfoliata [16] 41
獨活Du Huo Angelica archangelica [13-15] 41
茵陳蒿Yin Chen Hao Artemisia capillaris [14,15] 41
綠茶Lu Cha/Green tea/Chaso Camellia sinensis [13-15] 428
決明子Jue Ming Zi Cassia obtusifolia [13,14] 41
珠果黄堇Zh Guo Huang Jin, Hwang Geun Cho Corydalis speciose [13,14,16] 41
柘木Zhe Mu Cudrania tricuspidata [16] 41
白鮮皮Bai Xian Pi Dictamnus dasycarpus [13,14,16] 47
甘草Gan Cao, Liquorice Glycyrrhiza uralensis [13-15] 41
土三七Tu San QiGynura segetum/Radix Gynurae Segeti[13-15]44
枳椇子Ji Ju Zi, Jiguja Hovenia dulcis [13-15] 41
金不換Jin Bu Huan Lycopodium serratum [13,14] 43
川楝子Chuan Lian Zi Melia toosendan [13,14] 41
薄荷Bo He Mentha haplocalyx [13,14] 41
何首烏He Shou Wu, HoshouwuPolygoni multiflori/Polygonum multiflorum[9,13-16]480
葛根Ge Gen Pueraria lobata [13-15] 42
大黃Da Huang Rheum palmatum [13,14] 41
菝葜Ba QiaSmilacis Chinae Radix[16]41

Abbreviations: TCM, traditional Chinese medicine; RUCAM, Roussel Uclaf Causality Assessment Method.

Table 5.

TCM Herbs Found to Have Hepatotoxic Properties in the Laboratory Setting.

中草藥/成藥/方劑TCM Herb or Concoction
刺五加Acathopanax senticosus (Rupr et Maxim) Harms[33]
紅豆Adzuki bean (Phaseolus aureus Roxb)[34]
蛇葡萄Ampelopsis brevipedunculata (Maxim) Trautv (Vitaceae)[35]
牛樟芝 Antrodia camphorata [36,37]
黃花蒿Artemisia annua L[38]
赤小豆Black bean (Glycine max [L] Merr)[34]
綠豆Mung bean (Phaseolus radiatus L)[34]
三七 Panax notoginseng [29]
白芍Radix Paeoniae Alba[39]
赤芍Radix Paeoniae Rubra[39]
地黃 Rehmannia glutinosa [29]
黑豆Rice bean (Phaseolus calcaratus Roxb)[34]
丹參 Salvia miltiorhiza [40]
五味子 Schisandra chinensis [41]
蒼耳 Xanthium strumarium [42]
二至丸: 女貞子 旱蓮草Er-Zhi-Wan: Fructus Ligustri Lucidi, Herba Ecliptae[43]
桂枝茯苓丸:桂枝 茯苓 桃仁 芍藥 牡丹皮Guizhi-Fuling-Wan: Bark of Cinnamomum cassia Presl, Carpophores of Poria cocos Wolf, Seed of Prunus persica Batsch, Root of Paeonia lactiflora Pall, Root bark of Paeonia suffruticosa[44]
瀉青丸: 龍膽草 當歸 川芎 梔子 大黃 羌活 防風Shieh-Qing-Wan: Root of Angelica sinensis Diels (Umbelliferae) Root and rhizome of Gentiana scabra Bunge (Gentianaceae) Fruit of Gardenia jasminoides Ellis (Rubiaceae) Root and rhizome of Rheum palmatum L (Polygonaceae) Rhizome of Ligusticum chuanxiong Hort. (Umbelliferae) Root and rhizome of Notopterygium incisum Ting (Umibelliferae) Root of Saposhnikovia divaricata Schischk (Umbelliferae)[44]
四逆散:柴胡,白芍,枳實,甘草Si Ni San: Radix bupleuri, Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Glycyrrhizae[45]
四磨飲:人參,檳榔,沉香,烏藥Syh-Mo-Yiin: Root of Panax ginseng CA Meyer (Araliaceae) Seed of Areca eateehu L (Palmae) Lignum of i Roxb. (Euphorbiaceae) Root of Lindera strychn (/i~lia Vill (Lauraceae)[44]
茵陳蒿湯: 茵陳,梔子,大黃Yin Chen Hao Tang: Artemisia capillaris Thunb (Tarragon), Gardenia jasminoides Ellis (Gardenia), and Rheum officinale Baill (Rhubarb)[46]

Abbreviation: TCM, traditional Chinese medicine.

TCM Herbs That Were Assessed by RUCAM to Demonstrate Clear Causality of Hepatotoxicity. Abbreviations: TCM, traditional Chinese medicine; RUCAM, Roussel Uclaf Causality Assessment Method. TCM Concoctions That Were Assessed by RUCAM to Demonstrate Clear Causality of Hepatotoxicity. Abbreviations: TCM, traditional Chinese medicine; RUCAM, Roussel Uclaf Causality Assessment Method. Single Herbs With Hepatotoxic Risks. Herb Concoctions With Hepatotoxic Risks. TCM Herbs Found to Have Hepatotoxic Properties in the Laboratory Setting. Abbreviation: TCM, traditional Chinese medicine. We found 20, 17, 34, and 27 individual herbs that were graded level 4, 3, 2, and 1 for their causality toward liver injury, respectively. For herbal concoctions, we found 6, 10, 7, and 2 concoctions that were graded level 4, 3, 2, and 1, respectively. There were in total 21 herbs or concoctions that were hepatoprotective in laboratory settings. Using RUCAM, clear causality (level 4) was established in 194 cases of TCM-induced liver toxicity.

Discussion

TCM for Symptom Relief and Body Enhancement

He Shou Wu (何首烏, Polygoni multiflori) is traditionally used for treating premature whitening of hair, dizziness, and insomnia due to the insufficiency of essence and blood.[47] This makes He Shou Wu a popular choice among cancer patients to counter the side effects of chemotherapy such as alopecia. According to our results, there were 80 cases reaching level 4 (clearly established causality), 147 cases reaching level 3 (possible causality), and 516 cases attaining level 2 (clinical suspicion). Furthermore, when He Shou Wu was coadministered with other drugs as herbal concoctions, there were 37 cases that reached level 4. Therefore, there was clear evidence that He Shou Wu could cause liver injury. In TCM, Chuan Lian Zi (川楝子, Melia toosendan) is used for relieving pain,[48] and it is often used by cancer patients for pain control and to “relieve liver Qi congestion,” which is common among breast and liver cancer patients according to TCM theory. However, Chuan Lian Zi is known to have a slightly toxic property.[49] Our search results in a case (level 4) of Chuan Lian Zi–induced liver injury. Ren Shen (人參, Panax ginseng) has gained popularity in recent years. The annual world ginseng production was estimated to be 80 080 tons, and its global consumption has risen steadily over the years. Ginseng is being marketed as a natural health food and various forms are available.[50] Cancer patients take Ren Shen prepared in the form of tea, capsules, or as an ingredient in soup in the hope of increasing their “inner resistance.”[6] Ren Shen could be used for restoring Qi. It can treat severe vomiting, fatigue, diarrhea, shortness of breath, fatigue, feeble pulse, extreme weakness after severe disease, or prolonged illness.[47] During chemotherapy, patients might experience the above symptoms and may use this herb. Our review found a case of possible (level 3) hepatotoxicity caused by intravenous wild ginseng pharmacopuncture and 6 cases of suspected liver injury (level 2) caused by Ren Shen. Hence, further research should be done to confirm the causality of liver injury caused by this popular herb. San Qi (三七, Panax notoginseng) is a herb used to arrest bleeding and remove blood stasis in TCM. It is also known to be helpful in reducing swelling and relieving pain.[48] Hence, this herb might be used to reduce the pain caused by the tumor. According to laboratory findings, it was suggested that it has hepatoprotective effects. Unfortunately, another similarly named herb named Tu San Qi (土三七), or Radix Gynurae Segeti, has been proven to induce hepatic sinusoidal obstruction syndrome/veno-occlusive disease.[51] Contrary to the hepatoprotective San Qi, Tu San Qi led to 4 cases of liver injury (level 4). Hence, caution must be taken to avoid misidentification. Chai Hu (柴胡, Bupleurum falcatum) is an important component in Xiao Chai Hu Tang (小柴胡湯; XCHT). XCHT is a commonly used concoction to treat Shaoyang disease with symptoms such as chills and fever, nausea and dizziness, restlessness, fullness, discomfort at the chest, and dry throat.[48] Cancer patients may experience neutropenic fever, and XCHT is a common folk remedy that might be taken. Our results found that there were 4 cases of XCHT reaching level 4, while Chai Hu had 28 cases reaching level 2. On the other hand, Si Ni San, a concoction containing Chai Hu, is used to treat chronic hepatitis.[48] Si Ni San was found to be hepatoprotective in laboratory settings. We hypothesize that this could be due to the interaction between different herbs in concoctions. When herbs containing hepatotoxic constituents are boiled with other herbs, it is possible that new compounds that are nonhepatotoxic are formed. Another herb that showed conflicting results was Yin Chen Hao (茵陳蒿, Artemisia capillaris). Our literature search found that this herb causes liver injury, with 1 case of level 4 and 7 cases of level 2. On the contrary, Yin Chen Hao is used to treat jaundice in TCM. Oncology patients may take this herb to reduce jaundice. A concoction that uses Yin Chen Hao as a major herb, named Yin Chen Hao Tang (茵陳蒿湯), is also used for treating jaundice and diseases such as acute infectious icterohepatitis, acute cholecystitis, cholelithiasis, and leptospirosis in TCM. Our literature search found that laboratory findings suggesting Yin Chen Hao Tang has hepatoprotective properties. We postulate that as TCM herbs are rarely prescribed as a single herb, the other herbs that are prescribed concurrently may mitigate the hepatotoxic effects of Yin Chen Hao. Thus, in the form of a concoction, Yin Chen Hao Tang demonstrates hepatoprotective properties. Wu Wei Zi (五味子, Schisandra chinensis) is found to be hepatoprotective in our literature search. It is also known to be effective in lowering transaminase levels in those suffering from chronic hepatitis.[48] Hence, this herb may be taken by cancer patients to reduce the liver toxicity of systemic therapies and improve their liver function. Bai Shao (白芍, Radix Paeoniae Alba) is known to nourish the liver and treat diarrhea, dysentery, and pain.[48] This herb may be taken by cancer patients in hopes of improving their liver function. The results of our review echoed with its TCM use, as it was found to have hepatoprotective properties in the laboratory setting.

TCM With Anticancer Properties

Bai Xian Pi (白鮮皮, Dictamus dasycarpus) has been found to contain chemical constituents with cytotoxic properties.[52] One study showed the inhibitory effect of one of its chemical constituents on human breast cancer cells. Thus, it may be prescribed by TCM practitioners to patients for anticancer purposes.[53] However, our review found that Bai Xian Pi could cause hepatotoxicity, which could probably be explained by its cytotoxic properties. We found 7 and 32 cases that reached level 4 and 3, respectively. An interesting finding was Camellia sinensis (綠茶), commonly known as green tea, had 28 cases reaching level 4. In contrast, previous research has shown that green tea extract has antioxidant and antihepatotoxic properties.[54] Green tea was also reported to have anticancer properties. A review suggested green tea has anti–breast cancer activity by adjusting cell signaling pathways.[55] Its seeds were also found to have inhibitory effects on human ovarian cancer cells.[56] An extract also showed inhibitory effects on the growth of colorectal cancer cells.[57] We hypothesize that while there are certain chemical constituents that may be beneficial to health, green tea may also contain hepatotoxic constituents and may lead to liver injury when taken in large quantities. Huang Yao Zi (黃藥子, Dioscorea bulbifera L) is traditionally used to treat goiter, hyperthyroidism, and tumors,[48] and it could be prescribed to patients with thyroid cancer. However, it is known that overdose or long-term usage could lead to liver damage.[58] Surprisingly, no clinical cases of related hepatotoxicity were found in our literature search, only laboratory findings showed the potential of liver injury caused by this herb. This could be explained by the decreasing popularity and cautious use of this herb in clinical TCM practice nowadays. Our review found 1 case of Huang Qin (黃芩Scutellaria baicalnsis) that reached level 3 and 22 cases of level 2. This potentially hepatotoxic herb has been found to have anticancer properties, its chemical constituents were found to be cytotoxic to a broad range of human cancer cells, including brain tumor,[59] prostate cancer,[60] head and neck squamous cell carcinoma,[61] acute lymphocytic leukemia, lymphoma, and myeloma cell lines.[62] Topoisomerase inhibitors, like irinotecan and topotecan, are a type of chemotherapeutic agents that were derived from camptothecin from the bark of Camptotheca acuminata (Xishu, 喜樹). This TCM herb was found to reach level 2 of hepatotoxicity causality.

Causality Assessment

As demonstrated in the tables above, there are varying levels of evidence in the current literature. However, the clinical and histopathological features of herb-induced liver toxicity may mimic any liver injury histopathological model,[63] and expert judgement could be limited by subjectivity. Hence, a widely accepted and standardized algorithm is needed to confirm causality. RUCAM is a quantitative scale that has been used worldwide,[17,64-66] allowing results to be comparable across countries. When compared with other general causality assessment algorithms like the Naranjo scale, it is more liver-specific and more relevant.[12] Among liver-oriented methods, RUCAM was found to be superior. Clinical Diagnostic Scale showed poorer discriminative power, whereas the Digestive Disease Week-Japan scale included an in vitro drug lymphocyte stimulation test evaluation criterion, which was not widely accessible.[67] RUCAM also addresses other alternative causes of liver injury like concomitant drug use. Therefore, RUCAM is by far the most preferred algorithm used in the field.

Future Implications

First of all, we should note the presence of different types of evidence in the literature. Without following established causality algorithms, problems like comedication and poor data quality may affect the establishment of causality; hence, it is unjustifiable to ascertain the causal relationship immediately. Furthermore, contaminants during production and processing may lead to liver injury. Hence, clear-cut causality is often difficult to achieve. Our review presented the stratification of causality of the current literature. RUCAM is an important tool that should be applied to all future cases to determine causality accurately. Further studies are needed to confirm the causality of herb-induced liver injury with RUCAM in order to clarify the hepatotoxicity of herbs that are suspected in the literature. The use of RUCAM should be encouraged among physicians to aid diagnosis, and RUCAM should be employed before publication of cases and inclusion in databases. In Chinese communities, there is a common misconception that TCM is free of side effects and toxicities. Our review highlights the importance to evaluate the potential hepatotoxicity of TCM. We suggest that there is a fundamental need for raising the awareness of this issue among Chinese communities. Cancer patients should consult TCM practitioners before using TCM, instead of taking TCM without professional advice. Also, TCM can have hepatoprotective effects. However, proving the hepatoprotective effects of a herb clinically can be challenging, and the therapeutic benefit of TCM is often questioned. TCM herbs are rarely used alone, as each patient receives a personally tailored concoction. Hence, the effectiveness of TCM is difficult to be proven in the Western-dominated setting based on a medical system that treats the same disease with the same drug on different patients. In practice, oncologists are often uncertain of the efficacy and safety of TCM and therefore urge patients not to take any TCM during systemic treatment. TCM has been practiced for over 2000 years, and its ideologies and effectiveness have been deeply rooted and accepted in Chinese communities. A survey done in Hong Kong found that over two thirds of all interviewed Chinese cancer patients believed that integrated TCM and Western medicine was effective in treating cancer.[7] Hence, Chinese cancer patients are keen to use TCM. The total rejection by some oncologists may prompt patients to hide the truth. The aforementioned survey found that among patients who were concurrently receiving Western medicine treatment and TCM, nearly two thirds of them did not inform their physicians. This is not only harmful to the doctor-patient relationship but also unhelpful in monitoring and treating the patient. Recent research has shown that certain TCM when used in combination with Western medicine can be beneficial. It was found that some TCM could act as effective chemosensitizers and radiosensitizers, and could be helpful in palliative care.[68] We have learnt from history that some modern anticancer drugs were derived from plants. The Pacific Yew, the Madagascar Periwinkle, and the Chinese happy tree have yielded valuable chemicals for chemotherapy. If TCM was excluded from treating cancer patients, the advancement of cancer therapy may be hindered. More research is needed to clarify the hepatotoxicity and hepatoprotectiveness of different TCM herbs and concoctions. This is crucial to aid TCM practitioners and Western medicine doctors in making clinical decisions, as well as paving the way for TCM and Western medicine integration in treating cancer.

Conclusion

This literature review compiled a list of hepatotoxic and hepatoprotective TCM herbs and concoctions, and highlighted some that are highly likely to be used by cancer patients as they either have anticancer properties or symptom relief purposes. They were then stratified according to their levels of causality, to provide a clearer and more clinically relevant picture of the current evidence. More stringent research with the use of RUCAM is needed to confirm the causality of herb-induced liver injury before publication and inclusion in databases. Cancer patients should note the potential hepatotoxic effects of TCM herbs and should not assume the absence of side effects of TCM herbs. More collaboration between TCM and Western medicine should be encouraged to establish effective and safe screening of drug-herb interaction.
LevelContextDescription
1NonclinicalThe publication shows that certain TCM herbs/concoctions or their chemicals lead to hepatotoxicity in a laboratory setting. The experiments were conducted with animals or human cells.
2ClinicalThe publication suspected certain TCM herbs/concoctions would lead to hepatotoxicity, or associated certain TCM herbs/concoctions with hepatotoxicity. No causality was established.
3ClinicalThe publication suggested that certain TCM herbs/concoctions caused hepatotoxicity. Causality was ascertained by RUCAM in which cases were graded “possible,” or by other assessment algorithms like the positive reexposure test.
4ClinicalThe publication suggested that certain TCM herbs/concoctions caused hepatotoxicity. Clear causality was ascertained by RUCAM, in which cases were graded “probable” or higher.[13]
Table 2.

TCM Concoctions That Were Assessed by RUCAM to Demonstrate Clear Causality of Hepatotoxicity.

中成藥/方劑名稱TCM ConcoctionsLevel of CausalityNo. of Cases
丹鹿通督片: 丹参、鹿角膠、黄芪、延胡索、杜仲Dan Lu Tong Du tablet: Salvia miltiorrhiza, Cervi cornus Colla, Astragalus membranaceus, Corydalis yanhusuo, Eucommia ulmoides[17]48
首烏片:牛膝,菟絲,鱧腸,女楨,忍冬,桑白皮,何首烏,補骨脂,地黃,金櫻子,芝麻,豨薟Shou Wu Pian: Achyranthes bidentata, Cuscuta chinensis, Eclipta prostrata, Ligustrum lucidum, Lonicera japonica, Morus alba, Polygonum multiflorum, Psoralea corylifolia, Rehmannia glutinosa, Rosa laevigata, Sesamum indicum, Siegesbeckia orientalis[13,14]428
小柴胡湯:柴胡,人參,甘草,半夏,黃芩,薑和大棗Syosaikoto/Xiao Chai Hu Tang: Bupleurum falcatum, Ginseng, Glycyrrhiza glabra, Pinellia tuber, Scutellaria baicalensis, Zingiber officinale, Zizyphus jujuba[13,14]44
消銀膠囊: 地黃,芍藥,白芍,當歸,苦參,金銀花,玄參,牛蒡子,蟬蛻,黃芩,防風,大青葉,紅花Xiao Yin pill: Rehmannia glutinosa, Paeonia suffruticosa, Paeonia lactiflora, Angelica sinensis, Sophora flavescens, Lonicera japonica, Scrophularia ningpoensis, Arctium lappa, Periostracum cicadae, Cortex dictamni, Saposhnikovia divaricata, Folium isatidis, Carthamus tinctorius[17]46
養血生髮膠囊:熟地黃,當歸,羌活,木瓜,川芎,白芍,菟絲子,天麻,制何首烏Yang Xue Sheng Fa capsule: Radix rehmanniae preparata, Angelica sinensis, Notopterygium incisum, Chaenomeles speciosa, Ligusticum chuanxiong, Paeonia lactiflora, Semen cuscutae, Gastrodia elata, Radix polygoni multiflori preparata[17]49
熱多寒少湯加大黄:大黃,葛根,黃芩,細葉藁本,萊菔子,桔梗,升麻,白芷Yeoldahanso-tang plus Rheum rhabarbarum: Rhei Radix et Rhizomaa, Pueraria thunbergiana Bentham, Scutellariae Radix, Ligusticum tenuissimum Kitagawa, Raphani Semen, Platycodonis Radix, Cimicifuga heracleifolia, Angelicae Dahuricae Radix[16]41

Abbreviations: TCM, traditional Chinese medicine; RUCAM, Roussel Uclaf Causality Assessment Method.

Table 3.

Single Herbs With Hepatotoxic Risks.

中藥名Commonly Known asScientific NameLevel of CausalityNo. of Case
雞骨草Ji Gu Cao Abrus cantoniensis [13-15] 31
刺五加Ci Wu Jia Acanthopanax senticosus [14] 31
刺五加Ci Wu Jia Acanthopanax senticosus [13-15] 22
七日暈Qi Ri Yun, Chi R Yun Breynia officinalis [13,14,24] 319
七日暈Qi Ri Yun, Chi R Yun Breynia officinalis [14,15] 22
綠茶Lu Cha/Green tea/Chaso Camellia sinensis [13,14] 312
綠茶Lu Cha/Green tea/Chaso Camellia sinensis [14] 2121
綠茶Lu Cha/Green tea/Chaso Camellia sinensis [18] 1
積雪草Ji Xue Cao, Gotu kola Centella asiatica [14] 31
積雪草Ji Xue Cao, Gotu kola Centella asiatica [15] 22
鯇魚膽Carp gallbladder Ctenopharyngodon idella [25] 31
白鮮皮Bai Xian Pi Dictamnus dasycarpus [16] 332
白鮮皮Bai Xian Pi Dictamnus dasycarpus [14,15] 220
麻黃Ma Huang Ephedra sinica [14] 31
麻黃Ma Huang Ephedra sinica [14,15] 26
麻黃Ma Huang Ephedra species [18] 1
土三七Tu San QiGynura segetum/Radix Gynurae Segeti[14]32
土三七Tu San QiGynura segetum/Radix Gynurae Segeti[14,17,19]2171
枳椇子Ji Ju Zi, Jiguja Hovenia dulcis [14] 31
枳椇子Ji Ju Zi, Jiguja Hovenia dulcis [14] 21
金不換Jin Bu Huan Lycopodium serratum [14] 31
金不換Jin Bu Huan Lycopodium serratum [14,15] 210
人參Ren Shen, GinsengIntravenous Wild Ginseng Pharmacopuncture[16]31
人參Ren Shen, Ginseng Panax ginseng [13-15] 26
何首烏He Shou Wu, HoshouwuPolygoni multiflori/Polygonum multiflorum[9,16]3147
何首烏He Shou Wu, HoshouwuPolygoni multiflori/Polygonum multiflorum[13,15,17,21]2516
何首烏He Shou Wu, HoshouwuPolygoni multiflori/Polygonum multiflorum[9,19,21-23]1
葉下珠Ye XiaZhu Phyllanthus urinaria [13-15] 31
黃芩Huang Qin Scutellaria baicalensis [13,14] 31
黃芩Huang Qin Scutellaria baicalensis [13-15] 222
血見愁Xue Jian Chou Teucrium viscidum [26] 31
翼枝榆Yi Zhi YuUlmus davidiana var japonica Nakai[16]33
附子Fu Zi Aconitum carmichaeli [17] 213
當歸Dang Gui Angelica sinensis [13,15] 2
茵陳蒿Yin Chen Hao Artemisia capillaris [14,15] 27
柴胡Chai Hu Bupleurum falcatum [13-15] 228
決明子Jue Ming Zi Cassia obtusifolia [15,17] 218
喜樹Xi Shu Camptotheca acuminata [13-15] 2
及己Ji Ji Chloranthus serratus [13-15] 2
珠果黄堇Zh Guo Huang Jin,Hwang Geun Cho Corydalis speciosa [15] 2
延胡索Yan Hu Suo Corydalis yanhusuo [17] 236
延胡索Yan Hu Suo Corydalis yanhusuo [18] 1
瞿麥Qu Mai Dianthus superbus [20] 21
常山Chang Shan Dichroa root [20] 21
常山Chang ShanDichroa febrifuga Lour[13]1
五倍子Wu Bei Zi Galla chinensis [13-15] 2
毛果天芥菜Mao Guo Tian Jie Cai Heliotropium lasiocarpum [13-15] 24
紫草科植物 Heliotropium [18] 1
益母草Yi Mu Cao Leonuri japonici [20] 21
川楝子Chuan Lian ZiMelia toosendan fruit[15,20]21
薄荷Hu Bo He You Mentha pulegium [13-15] 2
石榴皮Shi Liu Pi Pericarpium granati [13-15] 2
虎杖Hu Zhang Polygonum cuspidatum [13-15] 2
破故紙Po Gu Zhi, Bol Gol Zhee Psoralea corylifolia [13-17] 244
葛屬植物Kudzu Pueraria thunbergiana [13-15] 26
大黃Da HuangRheum officinale/Rheum palmatum[15,17]224
丹蔘Dan ShenSalvia miltiorrhiza root[20]21
天花粉Tian Hua Fen Trichosanthes kirilowii [13-15] 2
合歡皮He Huan Pi Albizia julibrissin [13] 1
艾葉Ai Ye Artemisia argyi [13] 1
蒼朮苷Cang Zhu Gan Atractylis gummifera [18] 1
小米辣Xiao Mi La, Tobasco pepper Capsicum frutescens [18] 1
杜仲Du Zhung Cortex eucommiae [27] 1
豬屎豆Zhu Shi Dou Crotalaria [18] 1
莪朮E Zhu Curcuma phaeocaulis [27] 1
黃藥子Huang Yao ZiDioscorea bulbifera L[13,27]1
八角蓮Ba Jiao Lian Dysosma versipellis [27] 1
吳茱萸Wu Zhu Yu Evodia rutaecarpa [27] 1
苦楝子Ku Lian Zi Melia azedarach [13] 1
石花Shi Hua Parmelia saxatilis [18] 1
商陸Shang LuPhytolacca acinosa Roxb[13]1
苦參Ku Shen Radix sophora [27] 1
重樓皂苷Chong Lou Zao GanRhizoma Paridis saponins[30]1
肉豆蔻Rou Dou Kou Semen myristicae [27] 1
千里光Qian Li Guang Senecio scandens [13,18,27] 1
番瀉葉Fan Xie Ye Sennae folium [27] 1
雷公藤Lei Gong Teng Tripterygium wilfordii [13,28,29] 1
蒼耳子Cang Er ZiXanthium sibiricum/Xanthium strumarium L fruits[13,31]1
生姜Sheng JiangZingiber officinale Roscoe[27]1
Table 4.

Herb Concoctions With Hepatotoxic Risks.

中成藥/方劑TCM ConcoctionsLevel of CausalityNo. of Cases
丹鹿通督片: 丹参、鹿角膠、黄芪、延胡索、杜仲Dan-lu-tong-du tablet: Salvia miltiorrhiza, Cervi cornus Colla, Astragalus membranaceus, Corydalis yanhusuo, Eucommia ulmoides[17]31
首烏片:牛膝,菟絲,鱧腸,女楨,忍冬,桑白皮,何首烏,補骨脂,地黃,金櫻子,芝麻,豨薟Shou Wu Pian: Achyranthes bidentata, Cuscuta chinensis, Eclipta prostrata, Ligustrum lucidum, Lonicera japonica, Morus alba, Polygonum multiflorum, Psoralea corylifolia, Rehmannia glutinosa, Rosa laevigata, Sesemum indicum, Siegesbeckia orientalis[14]31
首烏片:牛膝,菟絲,鱧腸,女楨,忍冬,桑白皮,何首烏,補骨脂,地黃,金櫻子,芝麻,豨薟Shou Wu Pian: Achyranthes bidentata, Cuscuta chinensis, Eclipta prostrata, Ligustrum lucidum, Lonicera japonica, Morus alba, Polygonum multiflorum, Psoralea corylifolia, Rehmannia glutinosa, Rosa laevigata, Sesamum indicum, Siegesbeckia orientalis[14,15]217
防風通聖散:黃芩, 滑石, 甘草, 石膏, 桔梗, 防風, 川芎, 當歸, 白芍, 大黃,麻黃, 薄荷, 連翹, 芒硝, 荊芥, 白朮, 梔子Bangpungtongsung-san: Scutellariae Radixa, Talcum, Glycyrrhiza uralensis Fischer, gypsum, Platycodonis Radix, Saposhnikoviae Radix, Cnidii Rhizoma, Angelicae Gigantis Radix, Paeoniae Radix, Rhei Rhizoma, Ephedrae Herba, Menthae Herba, Forsythia suspensa Vahl, Natrii Sulfas, Schizonepetae Spica, Atractylodes macrocephala Koidzumi, Gardeniae Fructus[16]31
漢方防風通聖散:當歸,蒼朮,蛇床子,梔子,麻黃,連翹,甘草,石膏,防風,薄荷,牡丹,桔梗,大黃,荊芥,黃芩和姜; 滑石粉和硫酸鈉。Bofu Tsu Sho San: Angelica, Atractylis, Cnidium, Gardenia, Ephedra, Forsythia, Glycyrrhhiza, Gypsum fibrosum, Ledebouriella, Mentha, Paeonia, Platycodon, Rheum, Schizonepeta, Scutellaria and Zingiber; Kadinum (talcum powder), and sodium sulfuricum[13-15]21
加味五積散: 蒼朮, 陳皮, 厚朴, 桔梗, 枳殼, 當歸, 茯苓, 半夏, 川芎, 白芷, 肉桂, 桃仁, 紅花, 秦艽, 五加皮, 甘草, 生薑 東亞鉗蠍, 蜈蚣, 馬錢子, 白屈菜, 延胡索, 黃芩, 黃連, 蘆根, 草烏Gamiojuck-san: Atractylodis Rhizoma, Citrus unshiu Markovich, Magnolia officinalis, Platycodonis Radix, Aurantii Fructus Immaturus, Zingiber officinale, Angelicae Gigantis Radix, Poria Sclerotium, Pinellia ternata Breitenbach, Cnidium officinale Makino, Angelicae Dahuricae Radix, Cinnamomi Ramulus, Persicae Semen, Carthami Flos, Gentianae Macrophyllae Radix, Acanth opanacis Cortex, Glycyrrhiza uralensis Fischer, Zingiber officinale, Buthus martensii Karsch, Scolopendra, Strychni Semen, Chelidonii Herba, Corydalis Tuber, Scutellariae Radix, Coptidis Rhizoma, Phragmitis Rhizoma, Aconiti Kusnezoffii Tuber[16]31
加味六君子湯: 香附, 生姜, 大棗, 白朮, 茯苓, 陳皮, 半夏, 人参根, 紫蘇葉, 土木香, 砂仁Gamiyukgunja-tang: Cyperi Rhizoma, Zingiber officinale, Zizyphi Fructus, Atractylodes macroephala Koidzumi, Poria Sclerotium, Citrus unshiu Markovich, Pinellia ternata Breitenbach, Ginseng Radix, Perillae Folium, Inula helenium, Amomi Fructus[16]31
附子草烏加減方:附子 草烏Herbal Medicine including Boo-ja and Cheon-o: Aconiti Lateralis Radix Preparata, Aconiti Kusnezoffii Tuber were indicated and others were unknown[16]31
黄蓮加減方: 黃蓮Herbal Medicine Including Coptidis Rhizoma: only Coptidis Rhizoma was indicated in original article; others were unknown[16]31
白鮮加減方:白鮮, 葛根, 升麻, 蒺藜, 浮萍, 麥冬, 地黃, 甘草Herbal medicine including Dyctamnus dasycarpus: Dictamnus dasycarpusa, Pueraria thunbergiana Bentham, Cimicifuga heracleifolia, Tribulus terrestris L, Spirodelae Herba, Liriopis seu Ophiopogonis Tuber, Rehmanniae Radix Preparata, Glycyrrhiza uralensis Fischer[16]31
少陽人獨活地黄湯:山茱萸,茯苓,澤瀉,牡丹皮,防風,東北土當歸(+石膏)Soyangin Dokwhaljiwhang-tang: Rehmanniae Radix Preparata, Cornus officinalis, Poria Sclerotium, Alismatis Rhizoma, Moutan Radicis Cortex, Saposhnikoviae Radix, Araliae Continentalis Radix (+gypsum)[16]31
六味地黄元:澤瀉,地黃,山茱萸,山藥,麥冬,澤瀉,牡丹皮,茯苓Yugmijihwang-won: Alismatis Rhizomaa, Rehmanniae Radix Preparata, Cornus officinalis, Dioscoreae Rhizoma, Alismatis Rhizoma, Moutan Radicis Cortex, Poria Sclerotium[16]31
大柴胡湯: 柴胡,人參,甘草,半夏,黃芩,薑和棗樹Da Chai Hu Tang: Bupleurum falcatum, Ginseng, Glycyrrhiza glabra, Pinellia, Scutellaria, Zingiber officinale, and Zizyphus jujuba[13-15]21
複方青黛丸: 白芷,板藍根,神曲,丹參,土茯苓Fufangqingdaiyuan: Angelica dahurica, Isatis indigotica (Indigo naturalis), Massa medicata fermentata (yeast), Salvia milthiorrhiza, Smilax glabra[13,14]21
漢方加味逍遥散:當歸,白朮,柴胡,梔子,甘草,薄荷,牡丹皮,白芍,菌核和姜Kamishoyosan: Angelica sinensis, Atractylodes racea, Bupleurum falcatum, Gardenia, Glycyrrhiza glabra, Mentha haplocalyx, Moutan, Paeonia alba, Sclerotium Poriae Cocos, and Zingiber officinale[13-15]21
龍丹瀉肝湯:木通,澤瀉,當歸,柴胡,梔子,龍膽,甘草,車前子,熟地黃和黃芩Long Dan Xie Gan Tang: Acebia, Alisma, Angelica sinensis, Bupleurum, Gardenia, Gentiana, Glycyrrhiza, Plantago, Rehmannia, and Scutellaria[13-15]217
小柴胡湯:柴胡,人參,甘草,半夏,黃芩,薑和大棗Syosaikoto/Xiao Chai Hu Tang: Bupleurum falcatum, Ginseng, Glycyrrhiza glabra, Pinellia tuber, Scutellaria baicalensis, Zingiber officinale, Zizyphus jujuba[14,15]220
小柴胡湯: 柴胡,人參,甘草,半夏,黃芩,薑和大棗Syosaikoto/Xiao Chai Hu Tang: Bupleurum falcatum, Ginseng, Glycyrrhiza glabra, Pinellia tuber, Scutellaria baicalensis, Zingiber officinale, Zizyphus jujuba[23]1
桃紅四物湯: 桃仁,紅花,熟幹地黃,當歸,赤芍,川芎Tao-hong-si-wu decoction: Semen Persicae, Flos Carthami, Radix Rehmanniae, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong[32]1
  63 in total

1.  Ampelopsis brevipedunculata (Vitaceae) extract inhibits a progression of carbon tetrachloride-induced hepatic injury in the mice.

Authors:  N Yabe; H Matsui
Journal:  Phytomedicine       Date:  2000-12       Impact factor: 5.340

Review 2.  Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition.

Authors:  R Wong; C M Sagar; S M Sagar
Journal:  Cancer Treat Rev       Date:  2001-08       Impact factor: 12.111

3.  Evaluation of the protective effects of Schisandra chinensis on Phase I drug metabolism using a CCl4 intoxication model.

Authors:  M Zhu; K F Lin; R Y Yeung; R C Li
Journal:  J Ethnopharmacol       Date:  1999-10       Impact factor: 4.360

4.  Evaluation of hepatoprotective activity of legumes.

Authors:  S J Wu; J S Wang; C C Lin; C H Chang
Journal:  Phytomedicine       Date:  2001-05       Impact factor: 5.340

5.  Antioxidant and hepatoprotective effects of Acathopanax senticosus.

Authors:  C C Lin; P C Huang
Journal:  Phytother Res       Date:  2000-11       Impact factor: 5.878

6.  Acute poisonings with Breynia officinalis--an outbreak of hepatotoxicity.

Authors:  Tzeng-Jih Lin; Ching-Chyuan Su; Chi-Kin Lan; Donald D Jiang; Jin-Lian Tsai; Mee-Sun Tsai
Journal:  J Toxicol Clin Toxicol       Date:  2003

7.  Alleviating effects of si-ni-san, a traditional Chinese prescription, on experimental liver injury and its mechanisms.

Authors:  Jieyun Jiang; Chunxiang Zhou; Qiang Xu
Journal:  Biol Pharm Bull       Date:  2003-08       Impact factor: 2.233

8.  Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.

Authors:  David Y Zhang; Josephine Wu; Fei Ye; Li Xue; Shiquan Jiang; Jizu Yi; Wandi Zhang; Huachen Wei; Max Sung; Wayne Wang; Xiaoping Li
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Family beliefs about diet and traditional Chinese medicine for Hong Kong women with breast cancer.

Authors:  Peggy Burrows Simpson
Journal:  Oncol Nurs Forum       Date:  2003 Sep-Oct       Impact factor: 2.172

10.  Antioxidative and hepatoprotective effects of Antrodia camphorata extract.

Authors:  George Hsiao; Ming-Yi Shen; Kuan-Hung Lin; Ming-Huang Lan; Li-Yu Wu; Duen-Suey Chou; Chien-Huang Lin; Ching-Hua Su; Joen-Rong Sheu
Journal:  J Agric Food Chem       Date:  2003-05-21       Impact factor: 5.279

View more
  5 in total

1.  Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network.

Authors:  Xiang Qian; Zhuo Chen; Sha Sha Chen; Lu Ming Liu; Ai Qin Zhang
Journal:  J Immunol Res       Date:  2020-05-20       Impact factor: 4.818

2.  Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug-induced liver injury.

Authors:  Zhan Zeng; Wei Yi; Jian-Ping Dong; Qi-Qi Chen; Fang-Fang Sun; Hui-Hui Lu; Yan-Jie Lin; Xiao-Yue Bi; Liu Yang; Yao Lu; Lu Zhang; Ming-Hui Li; Yao Xie
Journal:  Front Pharmacol       Date:  2022-08-05       Impact factor: 5.988

3.  Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats.

Authors:  Xinyi Gu; Shuwei Li; Mengna Lu; Ying Li; Qixue Wang; Long Chen; Yiqun Jia; Shan Cao; Ting Zhang; Mingmei Zhou; Xiaojun Gou
Journal:  Front Microbiol       Date:  2022-08-09       Impact factor: 6.064

4.  Screening of the Hepatotoxic Components in Fructus Gardeniae and Their Effects on Rat Liver BRL-3A Cells.

Authors:  Chunnan Li; Meng Lan; Jingwei Lv; Ye Zhang; Xiaochen Gao; Xu Gao; Lihua Dong; Guangming Luo; Hui Zhang; Jiaming Sun
Journal:  Molecules       Date:  2019-10-30       Impact factor: 4.411

5.  Herb-induced liver injury: Systematic review and meta-analysis.

Authors:  Vinícius Remus Ballotin; Lucas Goldmann Bigarella; Ajacio Bandeira de Mello Brandão; Raul Angelo Balbinot; Silvana Sartori Balbinot; Jonathan Soldera
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.